ZabBio, Inc. logo — ZabBio is dedicated to developing monoclonal antibody-based...

ZabBio, Inc.

ZabBio is dedicated to developing monoclonal antibody-based products in tobacco plants that address unmet needs.

Founded 2017 United States San Diego, United States 7 employees Health Care, Manufacturing +1

General Information

Company Name ZabBio, Inc.
Founded Year 2017
Location United States San Diego, United States
Employees 7
Industries Health Care, Manufacturing, Pharmaceutical
Social

BounceWatch is an independent company data service, not affiliated with ZabBio, Inc.. To contact ZabBio, Inc., visit zabbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About ZabBio, Inc.

ZabBio, Inc. is a health care and pharmaceutical startup established in 2017 and headquartered in the United States. The company is dedicated to developing monoclonal antibody-based products to address unmet needs in infectious diseases and reproductive health. With a focus on production at scale and cost, ZabBio aims to cater to large, cost-sensitive markets. The core team boasts extensive experience, having conducted previous clinical trials such as those of MB66 (IND # 122,010) and ZB06 (IND # 147,498), covering drug manufacture, designing nonclinical studies, regulatory filings, and overseeing Phase 1 trials. The collective experience of the team spans over 20 years in antibody discovery, engineering, manufacture, and nonclinical and clinical trials. Although the last investment and investors are currently undisclosed, ZabBio's innovative approach to addressing critical health concerns in a cost-effective manner presents potential for growth and impact in the pharmaceutical industry.

Taxonomy: monoclonal antibodies, biopharmaceuticals, infectious diseases, reproductive health, antibody-based products, drug development, clinical trials, antibody discovery, regulatory filings, tobacco plant production, scientific research, pharmaceutical manufacturing, scale production

No funding data available for ZabBio, Inc. yet.

ZabBio, Inc. Alternatives & Competitors

View All Alternatives
ZabBio, Inc. vs

Burrard Pharmaceuticals is a leader in technology transfer and drug development.

4 employees
Biotechnology, Manufacturing
ZabBio, Inc. vs

"THE FIRST PLANT-PRODUCED BIOLOGICS COMPANY IN SOUTH EAST ASIA REGION."

Seed
31 employees
Biopharma, Food and Beverage
ZabBio, Inc. vs

Tetra Bio-Pharma (TSX: TBP) (OTC-Pink: TBPMF) (FRA: JAM1) is a biopharmaceutical leader in cannabino...

Post-IPO Debt
5 employees
Biopharma, Biotechnology

FAQ About ZabBio, Inc.

ZabBio is dedicated to developing monoclonal antibody-based products in tobacco plants that address unmet needs.
ZabBio, Inc. was founded in 2017.
ZabBio, Inc. is headquartered in San Diego, United States.
ZabBio, Inc. operates in Health Care, Manufacturing and Pharmaceutical. Its work centres on monoclonal antibodies, biopharmaceuticals, infectious diseases and reproductive health.
ZabBio, Inc. has approximately 7 employees.
Top alternatives and competitors to ZabBio, Inc. include Burrard Pharmaceuticals, Baiyaphytopharm, Tetra Bio-Pharma , Romark, L.C., Pharmasset, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ZabBio, Inc. and Burrard Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ZabBio, Inc., https://bouncewatch.com/company/zabbio-inc, updated 28 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes